(Hypertension. 2001;38:30.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Pennington Biomedical Research Center, Human Genomics Laboratory (T. Rankinen, G.S., C.B.), Baton Rouge, La; the Division of Biostatistics (P.A., T. Rice, D.C.R.) and the Departments of Genetics and Psychiatry (D.C.R.), Washington University School of Medicine, St. Louis, Mo; the Physical Activity Sciences Laboratory (Y.C.C., J.G.) and the Laboratory of Molecular Endocrinology (J.G.), Laval University, Québec, Canada; the School of Kinesiology and Leisure Studies, University of Minnesota (A.S.L.), Minneapolis; the Department of Kinesiology, Indiana University (J.S.S.), Bloomington; and the Department of Health and Kinesiology, Texas A & M University (J.H.W.), College Station.
Correspondence to Dr Tuomo Rankinen, Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA 70808-4124. E-mail rankint{at}pbrc.edu
| Abstract |
|---|
|
|
|---|
]) were adjusted for age, gender, baseline body mass index, and baseline blood pressure. Two analytical strategies were used: a multipoint variance-components linkage analysis using all the family data and a single-point linkage analysis using pairs of siblings. In whites, promising linkages (lod score >1.75) were detected for baseline SBP80 on 10q23-q24 and for
SBP50 on 8q21. In addition, several chromosomal regions with suggestive evidence of linkage (lod score 1.0 to 1.75) were observed for SBP50 (22q11.2-q13), DBP50 (6q23-q27), SBP80 (2p24, 2q21, 14q11.1-q12, and 16q21), DBP80 (6q13-q21),
SBP50 (7p12-p13), and
DBP50 (5q31-q32). In blacks, DBP50, DBP80, and
DBP80 showed promising quantitative trait loci on 18p11.2, 11q13-q21, and 10q21-q23, respectively. Suggestive linkages were evident for DBP50 on 2p22-p25, 11p15.5, and 18q21.1; for SBP80 on 6q21-q21, 6q31-q36, 12q12-q13, 15q12-q13, and 17q11-q12; and for DBP80 on 8q24, 10q21-q24, and 12p13. All the detected chromosomal regions include several potential candidate genes and therefore warrant further studies in the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) cohort and other studies.
Key Words: genes blood pressure exercise linkage
| Introduction |
|---|
|
|
|---|
25%, as derived from family studies, up to
70%, as derived from twin studies.1 The majority of the studies support a multifactorial model of inheritance with polygenic effects, although major gene effects contributing to BP variability have been reported.24 The search for genes affecting BP and hypertension has relied mainly on association and linkage studies using molecular markers at or near potential candidate gene loci. Several candidate genes have been tested, but the results have been mainly inconclusive, and the contribution of the genes showing positive associations has been moderate at best.5 An alternative strategy is to perform a genome-wide scan with the use of a large panel of polymorphic markers covering all chromosomes. This approach allows the detection of chromosomal regions that most likely harbor genes affecting the phenotype of interest. So far, 7 genomic scans for resting BP phenotypes612 and 1 scan for postural BP changes13 have been reported, and the number of promising quantitative trait loci (QTLs) has ranged from 1 to 6 per study. Several studies have shown the BP-lowering effect of regular endurance training, especially in subjects with high-normal BP levels and mild-to-moderate hypertension. In normotensive subjects, an exaggerated BP response to acute exercise has been suggested to predict the future risk of hypertension.14,15 Only a few studies have investigated the role of genetic factors in the regulation of BP response to exercise. For the acute exercise response, a segregation analysis study of 864 subjects from 81 pedigrees showed a mixed recessive model of transmission for diastolic BP (DBP) response to a cycle ergometer exercise test, with a gene frequency of 0.21. The phenotypic variances explained by the major gene and polygenic effects were 34% and 17%, respectively.16 In the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study, maximal heritability for acute systolic BP (SBP) response to submaximal exercise at 50 W in whites was 50%.17 The contribution of genetic factors to acute SBP and DBP responses to an incremental cycle ergometer test were also investigated in a cohort of 148 monozygotic and 111 dizygotic twin pairs with a mean age of 11 years.18 Significant genetic effects were found for SBP and DBP, and the results suggested that the genetic effects found at rest also influenced the exercise phenotypes, although the effects tended to decline with higher exercise intensities.
On the basis of these heritability estimates, it is reasonable to start looking for genomic regions and individual genes that are responsible for the genetic effects on exercise BP phenotypes. Using the data from the HERITAGE Family Study, we performed a genome-wide linkage scan for submaximal exercise SBP and DBP measured in the sedentary state and also in response to a 20-week endurance training program.
| Methods |
|---|
|
|
|---|
Blood Pressure
Before and after the 20-week training program, each subject completed 3 cycle ergometer (SensorMedics Ergo-Metrics 800S) exercise tests conducted on separate days: a maximal exercise test (Max), a submaximal exercise test (Submax), and a submaximal/maximal exercise test (Submax/Max).21 The Submax test was performed at 50 W and at 60% of the initial maximal oxygen consumption (VO2max). Subjects exercised for 8 to 12 minutes at each work rate, with a 4-minute period of seated rest between exercise periods. Finally, the Submax/Max test was started with the Submax protocol. After exercising at 60% VO2max, subjects also exercised for 3 minutes at 80% VO2max. The test then progressed to a maximal level of exertion. BP was obtained by using Colin STBP-780 automated units. Earphones allowed the technician to confirm the BP values selected by the detection algorithm of the instrument. For the present analyses, SBP and DBP measured at 2 different Submax intensity levels were selected. SBP and DBP at 50 W (SBP50 and DBP50, respectively) represent a moderate intensity level, whereas SBP and DBP at 80% VO2max (SBP80 and DBP80, respectively) reflect high-intensity exercise. BP was measured twice at each workload in both Submax tests, both before and after the training period, whereas only 1 BP recording was obtained at 80% VO2max. Thus, both the pretraining and posttraining 50 W phenotypes are the means of 4 measurements, whereas the 80% VO2max phenotypes represent a single measurement. BP training responses (
) were calculated as posttraining BP minus pretraining BP.
Exercise Training Program
The exercise training program has been described in detail previously.21 Briefly, the exercise intensity of the 20-week training program was customized for each participant on the basis of the heart rate-VO2 relationship measured at baseline. During the first 2 weeks, the subjects trained at a heart rate corresponding to 55% of the baseline VO2max for 30 minutes per session. Duration and intensity of the training sessions were gradually increased to 50 minutes and 75% of the heart rate associated with baseline VO2max; these levels were then sustained for the last 6 weeks. Training frequency was 3 times per week, and all training was performed on cycle ergometers in the laboratory. Heart rate was monitored during all training sessions by a computerized cycle ergometer system (Universal FitNet System), which adjusted ergometer resistance to maintain the target heart rate. Trained exercise specialists supervised all exercise sessions.
Data Adjustment
Baseline BP measurements were adjusted for the effects of gender, generation, and age by using stepwise multiple regression.22 Training response phenotypes were also adjusted for baseline value of the phenotype. In summary, a BP phenotype was regressed on up to a third-degree polynomial in age (separately within race-by-gender-by-generation subgroups). Only significant terms (5% level) were retained (ie, the model did not need to be saturated). The residual from this regression (or the raw score if no age terms were significant) was then standardized to 0 mean and unit variance and constituted the analysis variable. Similarly, a second set of BP variables (both baseline and training responses) was constructed by removing the effects of baseline body mass index (BMI) and the polynomial in age. For the training response phenotypes, we also checked the effect of training-induced changes in BMI (
BMI) on BP training responses.
BMI had no significant contribution in regression models and, therefore, was not included in the final models.
Molecular Studies
A total of 344 markers with an average spacing of 9.7 cM were used. Polymerase chain reaction conditions and genotyping methods have been fully outlined previously.23 Automatic DNA sequencers from LI-COR were used to detect the polymerase chain reaction products, and genotypes were scored automatically by using SAGA software. Incompatibilities of mendelian inheritance were checked, and markers showing incompatibilities were regenotyped completely (<10% were retyped). Microsatellite markers were selected mainly from the Marshfield panel, version 8a, as were some candidate genes for obesity and comorbidities, including hypertension. Map locations were taken mainly from the Genetic Location DataBase of Southampton, UK (which can be accessed online at http://cedar.genetics.soton.ac.uk) and from other sources for a few markers (published articles and the Marshfield Institute map can be accessed online at http://www.marshmed.org/genetics).
Linkage Analyses
Linkage analysis was performed by using a multipoint variance components model as implemented in SEGPATH.24,25 According to this model, a phenotype is influenced by the additive effects of a trait locus (g), a residual familial background modeled as a pseudopolygenic component, and a residual nonfamilial component (r). The effects of the trait locus and the pseudopolygenic component on the phenotype represent the heritabilities, h2g and h2r, respectively. Allele-sharing probabilities (at each marker location for each sibling pair) were used as input data for the linkage component of the SEGPATH model. These multipoint probabilities were derived by using the program MAPMAKER/SIBS.26 Other parameters in the model include spouse and additional sibling resemblance and the mean and variance in the offspring. The linkage hypothesis is tested by restricting the trait locus heritability to 0. A likelihood ratio test contrasts the null hypothesis (h2g=0) with the alternative (h2g estimated). The difference in -2 ln L (minus twice the log likelihood) between the null and alternate hypotheses is asymptotically distributed as a 50:50 mixture of a
12 and a point mass at 0, and the P value is half that associated with the
2 value.27 The lod score is
2/(2 · loge10). The
-level used here to identify promising results (P<0.0023, corresponding to a lod score of 1.75) represents, on average, 1 false positive per scan for experiments involving
400 markers.28
In addition to the multipoint linkage analyses, a single-point linkage analysis was performed with the sib-pair linkage procedure29,30 as implemented in the SIBPAL program of the SAGE Statistical Package.31 Briefly, the squared sib-pair phenotypic difference was regressed on the expected proportion of marker alleles identical-by-descent at the locus. A 1-sided t test was then used to test whether the regression coefficient is <0. A significant inverse relationship between the squared sib-pair phenotypic difference and allele sharing at the marker locus was taken as evidence of linkage. Both the multipoint and single-point analyses were conducted separately for blacks and whites.
| Results |
|---|
|
|
|---|
|
|
|
|
|
In whites, 1 chromosomal region (10q23-q24, Figure 1) showed promising linkages and another 8 regions (2p24, 2q21, 6q13-q21, 6q23-q27, 14q11.1-q12, 15q24-q25, 16q21, and 22q12-q13) showed suggestive linkages with baseline phenotypes (Table 2). For the training response phenotypes, 1 promising QTL (8q24 for
SBP80, Figure 1) and 2 suggestive QTLs (5q31-q33 for
DBP50 and 7p12p13 for
SBP50) were detected (Table 2). Of the 9 baseline BP QTLs, 6 were for SBP, whereas 3 were specific for DBP. Five of the SBP regions were specific for SBP80 (2p, 2q, 10q, 14q, and 16q), and 1 was specific for SBP50 only (22q). One QTL was detected for baseline DBP50 (6q), and 2 were detected for DBP80 (6q and 15q).
In blacks, 2 regions with promising linkages (11q13-q21 for DBP80 and 18p11.2 for DBP50, Figure 2) and 11 with suggestive linkages (2p22-p25 and 11p15.5 for DBP50; 6q21-q23, 7q31-q36, 12p12-p13, 15q26, 16q12-q13, and 17cen-q12 for SBP80; and 8q24, 10q21-q24, and 12p12-p13 for DBP80) were detected for the baseline phenotypes (Table 3). One region at 10q21-q23 showed promising linkage with the DBP80 training response (Table 3, Figure 2). No common QTLs were found for blacks and whites. Adjustment for baseline BMI did not have any major impact on linkages either in blacks or in whites.
| Discussion |
|---|
|
|
|---|
The strongest evidence of linkage was detected on chromosome 8, where the most distal marker (D8S373) on the long arm yielded a lod score of 2.36 for SBP50 training response in whites. In blacks, the same marker showed a suggestive linkage with baseline DBP80. The area harbors several potential candidate genes for BP regulation. Perhaps the most interesting one is the CYP11B1/CYP11B2 locus. CYP11B1 encodes a steroid 11ß-hydroxylase enzyme, which catalyzes the terminal step of cortisol biosynthesis. CYP11B2 encodes a related enzyme, aldosterone synthase, which has, in addition to steroid 11ß-hydroxylase activity, the 18-hydroxylase and 18-oxidase activities necessary for the final steps of aldosterone synthesis. Mutations in CYP11B1 and CYP11B2 genes lead to a hypertensive form of congenital adrenal hyperplasia32 and various forms of aldosterone synthase deficiencies characterized by hypotension,33 respectively. In addition, unequal recombination between these genes causes hypertensive disorder of glucocorticoid-suppressible hyperaldosteronism.34 To identify the gene(s) contributing to the linkage signals, however, it is necessary to define the QTLs more precisely, first with additional microsatellite markers and linkage analyses, then with linkage disequilibrium tests using single nucleotide polymorphisms, and finally, with resequencing of the strongest positional candidate genes.35 This approach will be used also for the QTLs reported in the present study.
A single genome-wide scan has a limited power to provide conclusive evidence for QTLs affecting BP phenotypes. Therefore, it is crucial to look for consistent trends across different studies to evaluate the true potential of genomic regions to harbor candidate genes. Unfortunately, there are no other genome-wide scans available for exercise BP phenotypes, but comparison of the present results with the previous resting BP scans reveals some common regions. For example, the D2S1334 marker that was linked with baseline SBP80 in whites in the present study also showed a suggestive linkage with resting SBP in the Genetic Epidemiology Network of Atherosclerosis (GENOA) cohort.6 Similarly, marker D15S657 was linked with baseline SBP80 in blacks of the HERITAGE Family Study, and the same marker was the nearest one to a resting DBP QTL in a Chinese cohort.7 In addition, a nearby marker (D15S652) was linked with resting SBP in the GENOA cohort,6 and another marker (D15S211) further upstream identified a QTL for baseline DBP80 in whites of the HERITAGE Family Study. Marker D14S283, located near the angiogenin locus on the short arm of chromosome 14, showed suggestive linkage with baseline SBP80 in the white cohort of the HERITAGE Family Study and with resting SBP in the Quebec Family Study.8 Finally, 2 markers at and near the ADRB2 locus showed suggestive evidence of linkage with the DBP50 training response in whites. In the GENOA network cohort, a QTL for resting BP was also detected at 5q,6 and further positional analyses revealed the ADRB2 locus to be responsible for the signal.36
The prevalence of hypertension has been shown to be higher among blacks than whites,20 and it has been suggested that the mechanisms leading to hypertension in blacks and whites may be different and that some of this variation may have a genetic origin.37 The majority of the subjects in the HERITAGE Family Study were normotensive, but nevertheless, both resting and exercise BPs at baseline were higher in blacks than in whites.38 The results of the present study indicate that the chromosomal regions harboring genes that affect exercise BP phenotypes may be different in blacks and whites. In some cases, however, a QTL was detected at the same region but for different phenotypes (ie, D10S677 with DBP80 in blacks and SBP80 in whites) or for the same phenotype but with an adjacent marker (ie, SBP80 with D16S264 in whites and D16S3253 in blacks). Interestingly, in Chinese families, a QTL for resting SBP was detected approximately between these 2 markers in chromosome 16.7
In summary, these data from the HERITAGE Family Study provide evidence of several genomic regions that potentially contain genes affecting submaximal exercise BP phenotypes in the sedentary state and in response to endurance training in blacks and whites. The linkage signals were detected in blacks and whites at different genomic regions, which may reflect interactions between QTLs and environmental factors. The exercise BP QTLs overlap, to some extent, those reported previously for resting BP phenotypes. These genomic regions should be explored further to identify the genes and characterize the mutations that contribute to observed interindividual variation in exercise BP phenotypes.
| Acknowledgments |
|---|
Received September 29, 2000;
first decision January 30, 2001;
| References |
|---|
|
|
|---|
2. Cheng LS, Carmelli D, Hunt SC, Williams RR. Evidence for a major gene influencing 7-year increases in diastolic blood pressure with age. Am J Hum Genet. 1995; 57: 11691177.[Medline] [Order article via Infotrieve]
3. Cheng LS, Livshits G, Carmelli D, Wahrendorf J, Brunner D. Segregation analysis reveals a major gene effect controlling systolic blood pressure and BMI in an Israeli population. Hum Biol. 1998; 70: 5975.[Medline] [Order article via Infotrieve]
4. Perusse L, Moll PP, Sing CF. Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am J Hum Genet. 1991; 49: 94105.[Medline] [Order article via Infotrieve]
5.
Corvol P, Persu A, Gimenez-Roqueplo AP, Jeunemaitre X. Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension. 1999; 33: 13241331.
6.
Krushkal J, Ferrell R, Mockrin SC, Turner ST, Sing CF, Boerwinkle E. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation. 1999; 99: 14071410.
7. Xu X, Rogus JJ, Terwedow HA, Yang J, Wang Z, Chen C, Niu T, Wang B, Xu H, Weiss S, et al. An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet. 1999; 64: 16941701.[Medline] [Order article via Infotrieve]
8.
Rice T, Rankinen T, Province MA, Chagnon YC, Perusse L, Borecki IB, Bouchard C, Rao DC. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation. 2000; 102: 19561963.
9.
Hsueh WC, Mitchell BD, Schneider JL, Wagner MJ, Bell CJ, Nanthakumar E, Shuldiner AR. QTL influencing blood pressure maps to the region of PPH1 on chromosome 2q3134 in old order Amish. Circulation. 2000; 101: 28102816.
10.
Sharma P, Fatibene J, Ferraro F, Jia H, Monteith S, Brown C, Clayton D, OShaughnessy K, Brown MJ. A genome-wide search for susceptibility loci to human essential hypertension. Hypertension. 2000; 35: 12911296.
11. Perola M, Kainulainen K, Pajukanta P, Terwilliger JD, Hiekkalinna T, Ellonen P, Kaprio J, Koskenvuo M, Kontula K, Peltonen L. Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens. 2000; 18: 15791585.[Medline] [Order article via Infotrieve]
12.
Levy D, DeStefano AL, Larson MG, ODonnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH. Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension. 2000; 36: 477483.
13.
Pankow JS, Rose KM, Oberman A, Hunt SC, Atwood LD, Djousse L, Province MA, Rao DC. Possible locus on chromosome 18q influencing postural systolic blood pressure changes. Hypertension. 2000; 36: 471476.
14. Matthews CE, Pate RR, Jackson KL, Ward DS, Macera CA, Kohl HW, Blair SN. Exaggerated blood pressure response to dynamic exercise and risk of future hypertension. J Clin Epidemiol. 1998; 51: 2935.[Medline] [Order article via Infotrieve]
15. American College of Sports Medicine. Position stand: physical activity, physical fitness, and hypertension. Med Sci Sports Exerc. 1993; 25: i-x.[Medline] [Order article via Infotrieve]
16. Cheng LS, Carmelli D, Hunt SC, Williams RR. Segregation analysis of cardiovascular reactivity to laboratory stressors. Genet Epidemiol. 1997; 14: 3549.[Medline] [Order article via Infotrieve]
17. Leon AS, An P, Rice T, Pérusse L, Gagnon J, Wilmore JH, Skinner JS, Rao DC, Bouchard C. Genetic determinants of exercise heart rate and blood pressure in the sedentary state: results from the HERITAGE Family. Ann Behav Med. In press.
18.
van den Bree MB, Schieken RM, Moskowitz WB, Eaves LJ. Genetic regulation of hemodynamic variables during dynamic exercise: the MCV twin study. Circulation. 1996; 94: 18641869.
19. Bouchard C, Leon AS, Rao DC, Skinner JS, Wilmore JH, Gagnon J. The HERITAGE family study: aims, design, and measurement protocol. Med Sci Sports Exerc. 1995; 27: 721729.[Medline] [Order article via Infotrieve]
20.
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997; 157: 2413 2446.
21. Skinner JS, Wilmore KM, Krasnoff JB, Jaskolski A, Jaskolska A, Gagnon J, Province MA, Leon AS, Rao DC, Wilmore JH, et al. Adaptation to a standardized training program and changes in fitness in a large, heterogeneous population: the HERITAGE Family Study. Med Sci Sports Exerc. 2000; 32: 157161.[Medline] [Order article via Infotrieve]
22. Rice T, Borecki IB, Bouchard C, Rao DC. Commingling analysis of regional fat distribution measures: the Quebec family study. Int J Obes Relat Metab Disord. 1992; 16: 831844.[Medline] [Order article via Infotrieve]
23. Chagnon YC, Borecki IB, Perusse L, Roy S, Lacaille M, Chagnon M, Ho-Kim MA, Rice T, Province MA, Rao DC, et al. Genome-wide search for genes related to the fat-free body mass in the Quebec family study. Metabolism. 2000; 49: 203207.[Medline] [Order article via Infotrieve]
24. Province MA, Rice T, Borecki IB, Gu C, Rao DC. A multivariate and multilocus variance components approach using structural relationships to assess quantitative trait linkage via SEGPATH. Genet Epidemiol. In press.
25. Province MA, Rao DC. General purpose model and a computer program for combined segregation and path analysis (SEGPATH): automatically creating computer programs from symbolic language model specifications. Genet Epidemiol. 1995; 12: 203219.[Medline] [Order article via Infotrieve]
26. Kruglyak L, Lander ES. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet. 1995; 57: 439454.[Medline] [Order article via Infotrieve]
27. Self GA, Liang KY. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. J Am Stat Assoc. 1987; 82: 605610.
28. Rao DC, Province MA. The future of path analysis, segregation analysis, and combined models for genetic dissection of complex traits. Hum Hered. 2000; 50: 3442.[Medline] [Order article via Infotrieve]
29. Amos CI, Elston RC, Wilson AF, Bailey-Wilson JE. A more powerful robust sib-pair test of linkage for quantitative traits. Genet Epidemiol. 1989; 6: 435449.[Medline] [Order article via Infotrieve]
30. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972; 2: 319.[Medline] [Order article via Infotrieve]
31. S.A.G.E. Statistical Analysis for Genetic Epidemiology [computer program]. Release 3.1. Cleveland, Ohio: Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University; 1998.
32.
Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, White PC, Pascoe L. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U.S.A. 1993; 90: 45524556.
33.
Pascoe L, Curnow KM, Slutsker L, Rosler A, White PC. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U.S.A. 1992; 89: 49965000.
34. Lifton RP. Molecular genetics of human blood pressure variation. Science. 1996; 272: 676680.[Abstract]
35.
Boerwinkle E, Hixson JE, Hanis CL. Peeking under the peaks: following up genome-wide linkage analyses. Circulation. 2000; 102: 18771878.
36.
Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E. Positional genomic analysis identifies the B2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation. 2000; 101: 28772882.
37.
ODonnell CJ, Kannel WB. Is there a racial predisposition to hypertension? Hypertension. 1998; 32: 817819.
38. Wilmore JH, Stanforth PR, Gagnon J, Rice T, Mandel S, Leon AS, Rao DC, Skinner JS, Bouchard C. Heart rate and blood pressure changes with endurance training: the HERITAGE Family Study. Med Sci Sports Exerc. 2001; 33: 107116.[Medline] [Order article via Infotrieve]
Related Article:
Hypertension 2001 38: 38-40.
This article has been cited by other articles:
![]() |
R. S. Vasan, N. L. Glazer, J. F. Felix, W. Lieb, P. S. Wild, S. B Felix, N. Watzinger, M. G. Larson, N. L. Smith, A. Dehghan, et al. Genetic Variants Associated With Cardiac Structure and Function: A Meta-analysis and Replication of Genome-wide Association Data JAMA, July 8, 2009; 302(2): 168 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lippi, U. G. Longo, and N. Maffulli Genetics and sports Br. Med. Bull., February 9, 2009; (2009) ldp007v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Spielmann, A. S. Leon, D. C. Rao, T. Rice, J. S. Skinner, T. Rankinen, and C. Bouchard Genome-wide linkage scan for submaximal exercise heart rate in the HERITAGE family study Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3366 - H3371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomaszewski, F. J. Charchar, M. D. Lynch, S. Padmanabhan, W. Y.S. Wang, W. H. Miller, W. Grzeszczak, C. Maric, E. Zukowska-Szczechowska, and A. F. Dominiczak Fibroblast Growth Factor 1 Gene and Hypertension: From the Quantitative Trait Locus to Positional Analysis Circulation, October 23, 2007; 116(17): 1915 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingelsson, M. G. Larson, R. S. Vasan, C. J. O'Donnell, X. Yin, J. N. Hirschhorn, C. Newton-Cheh, J. A. Drake, S. L. Musone, N. L. Heard-Costa, et al. Heritability, Linkage, and Genetic Associations of Exercise Treadmill Test Responses Circulation, June 12, 2007; 115(23): 2917 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pojoga, N. S. Kolatkar, J. S. Williams, T. S. Perlstein, X. Jeunemaitre, N. J. Brown, P. N. Hopkins, B. A. Raby, and G. H. Williams {beta}-2 Adrenergic Receptor Diplotype Defines a Subset of Salt-Sensitive Hypertension Hypertension, November 1, 2006; 48(5): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Farooqi, S. Drop, A. Clements, J. M. Keogh, J. Biernacka, S. Lowenbein, B. G. Challis, and S. O'Rahilly Heterozygosity for a POMC-Null Mutation and Increased Obesity Risk in Humans Diabetes, September 1, 2006; 55(9): 2549 - 2553. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Pausova, D. Gaudet, F. Gossard, M. Bernard, M. L. Kaldunski, M. Jomphe, J. Tremblay, T. J. Hudson, G. Bouchard, T. A. Kotchen, et al. Genome-Wide Scan for Linkage to Obesity-Associated Hypertension in French Canadians Hypertension, December 1, 2005; 46(6): 1280 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cai, S. A Cole, R. A Bastarrachea-Sosa, J. W MacCluer, J. Blangero, and A. G Comuzzie Quantitative trait locus determining dietary macronutrient intakes is located on human chromosome 2p22 Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1410 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. F. Loos, P. T. Katzmarzyk, D. C. Rao, T. Rice, A. S. Leon, J. S. Skinner, J. H. Wilmore, T. Rankinen, and C. Bouchard Genome-Wide Linkage Scan for the Metabolic Syndrome in the HERITAGE Family Study J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5935 - 5943. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Camp, P. N. Hopkins, S. J. Hasstedt, H. Coon, A. Malhotra, R. M. Cawthon, and S. C. Hunt Genome-Wide Multipoint Parametric Linkage Analysis of Pulse Pressure in Large, Extended Utah Pedigrees Hypertension, September 1, 2003; 42(3): 322 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kotchen, U. Broeckel, C. E. Grim, P. Hamet, H. Jacob, M. L. Kaldunski, J. M. Kotchen, N. J. Schork, P. J. Tonellato, and A. W. Cowley Jr Identification of Hypertension-Related QTLs in African American Sib Pairs Hypertension, November 1, 2002; 40(5): 634 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomaszewski, N. J.R. Brain, F. J. Charchar, W. Y.S. Wang, B. Lacka, S. Padmanabahn, J. S. Clark, N. H. Anderson, H. V. Edwards, E. Zukowska-Szczechowska, et al. Essential Hypertension and {beta}2-Adrenergic Receptor Gene: Linkage and Association Analysis Hypertension, September 1, 2002; 40(3): 286 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rankinen, P. An, L. Perusse, T. Rice, Y. C. Chagnon, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, et al. Genome-wide linkage scan for exercise stroke volume and cardiac output in the HERITAGE Family Study Physiol Genomics, August 14, 2002; 10(2): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hunt, R. C. Ellison, L. D. Atwood, J. S. Pankow, M. A. Province, and M. F. Leppert Genome Scans for Blood Pressure and Hypertension: The National Heart, Lung, and Blood Institute Family Heart Study Hypertension, July 1, 2002; 40(1): 1 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Lim and T. Rankinen Role of Aldosterone in the Pathogenesis of Hypertension * Response Hypertension, February 1, 2002; 39 (2): e14 - e14. [Full Text] [PDF] |
||||
![]() |
F. C. Luft and A. Busjahn Peaks and Valleys Hypertension, July 1, 2001; 38(1): 38 - 40. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |